References
- Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602
- Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003;64:1465–75
- Detke MJ, Lu Y, Goldstein DJ, et al. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. J Psychiatr Res 2002;36:383–90
- Detke MJ, Lu Y, Goldstein DJ, et al. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002;63:308–15
- Detke MJ, Wiltse CG, Mallinckrodt CH, et al. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol 2004;14:457–70
- Goldstein DJ, Mallinckrodt C, Lu Y, et al. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry 2002;63:225–31
- Cymbalta [package insert]. Indianapolis, IN: Eli Lilly and Company, 2011
- Liu XC, Gelwick S, Faries D, et al. Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder. Int Clin Psychopharmacology 2010;25:315–22
- Venturini F, Sung JCY, Nichol MB, et al. Utilization patterns of antidepressant medications in a patient population served by a primary care medical group. J Manag Care Pharm 1999;5:243–9
- Faries DE, Nyhuis AW, Ascher-Svanum H. Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example. Cost Eff Resour Alloc 2009;7:11
- Breiman L, Freidman L, Olshen RA, et al. Classification and regression trees. Boca Raton, FL: Chapman & Hall/CRC, 1984
- Lemon SC, Roy J, Clark MA, et al. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003;26:172–81
- Weilburg JB, Stafford RS, O'Leary KM, et al. Costs of antidepressant medications associated with inadequate treatment. Am J Manag Care 2004;10:357–65
- Russell JM, Berndt ER, Miceli R, et al. Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline. Am J Manag Care 1999;5:597–606
- Panzarino PJ Jr, Nash DB. Cost-effective treatment of depression with selective serotonin reuptake inhibitors. Am J Manag Care 2001;7:173–84
- Camacho F, Kong MC, Sheehan DV, et al. Expenditures associated with dose titration at initiation of therapy in patients with major depressive disorder: a retrospective analysis of a large managed care claims database. P T 2010;35:452–68